Additional file 2: Figure S2. of Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study Tomoyuki Hayashi Taro Yamashita Takeshi Terashima Tsuyoshi Suda Hikari Okada Yoshiro Asahina Takehiro Hayashi Yasumasa Hara Kouki Nio Hajime Sunagozaka Hajime Takatori Kuniaki Arai Yoshio Sakai Tatsuya Yamashita Eishiro Mizukoshi Masao Honda Shuichi Kaneko 10.6084/m9.figshare.5722183.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Figure_S2_of_Serum_cytokine_profiles_predict_survival_benefits_in_patients_with_advanced_hepatocellular_carcinoma_treated_with_sorafenib_a_retrospective_cohort_study/5722183 Comparison of serum IL-5, CXCL9, and VGEF-A levels between long survivors and non-long survivors in the 2 cohorts. (PDF 117 kb) 2017-12-19 05:00:00 Hepatocellular carcinoma Sorafenib Hepatic arterial infusion chemotherapy Cytokine Chemokine Growth factor